US Stock MarketDetailed Quotes

Monopar Therapeutics (MNPR)

Watchlist
  • 69.070
  • -0.530-0.76%
Close Jan 15 16:00 ET
  • 69.070
  • 0.0000.00%
Post 16:20 ET
461.57MMarket Cap-17.44P/E (TTM)

Monopar Therapeutics (MNPR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
159.89%4.09M
80.81%3.23M
86.95%3.22M
83.01%16.16M
479.22%11.07M
-23.77%1.57M
-23.17%1.79M
-31.75%1.72M
-16.19%8.83M
-34.27%1.91M
Selling and administrative expenses
154.53%1.5M
128.68%1.5M
108.44%1.58M
-2.33%3.16M
31.22%1.15M
-21.19%590.62K
-10.32%657.81K
-13.12%757.28K
9.70%3.23M
8.73%876.4K
-General and administrative expense
154.53%1.5M
128.68%1.5M
108.44%1.58M
-2.33%3.16M
31.22%1.15M
-21.19%590.62K
-10.32%657.81K
-13.12%757.28K
9.70%3.23M
8.73%876.4K
Research and development costs
163.11%2.59M
52.96%1.73M
70.10%1.64M
132.24%13.01M
858.35%9.92M
-25.24%984.28K
-29.08%1.13M
-41.57%966.11K
-26.23%5.6M
-50.76%1.04M
Operating profit
-159.89%-4.09M
-80.81%-3.23M
-86.95%-3.22M
-83.01%-16.16M
-479.22%-11.07M
23.77%-1.57M
23.17%-1.79M
31.75%-1.72M
16.19%-8.83M
34.27%-1.91M
Net non-operating interest income expense
559.80%655.47K
962.63%780.77K
626.40%596.85K
-5.83%404.02K
51.96%149.04K
-11.51%99.34K
-42.70%73.48K
-9.20%82.17K
1,920.05%429.04K
674.67%98.07K
Non-operating interest income
559.80%655.47K
962.63%780.77K
626.40%596.85K
-5.83%404.02K
51.96%149.04K
-11.51%99.34K
-42.70%73.48K
-9.20%82.17K
1,920.05%429.04K
674.67%98.07K
Other net income (expense)
171.28K
0
171.28K
Other non- operating income (expenses)
----
----
----
--171.28K
--0
--171.28K
----
----
----
----
Income before tax
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
Income tax
Net income
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
Net income continuous Operations
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
Minority interest income
Net income attributable to the parent company
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-85.50%-15.59M
-502.32%-10.93M
33.24%-1.3M
22.03%-1.72M
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
Basic earnings per share
-29.73%-0.48
28.57%-0.35
25.49%-0.38
-35.20%-4.11
-350.82%-2.75
46.38%-0.37
38.75%-0.49
46.32%-0.51
26.75%-3.04
46.96%-0.61
Diluted earnings per share
-29.73%-0.48
28.57%-0.35
25.49%-0.38
-35.20%-4.11
-350.82%-2.75
46.38%-0.37
38.75%-0.49
46.32%-0.51
26.75%-3.04
46.96%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 159.89%4.09M80.81%3.23M86.95%3.22M83.01%16.16M479.22%11.07M-23.77%1.57M-23.17%1.79M-31.75%1.72M-16.19%8.83M-34.27%1.91M
Selling and administrative expenses 154.53%1.5M128.68%1.5M108.44%1.58M-2.33%3.16M31.22%1.15M-21.19%590.62K-10.32%657.81K-13.12%757.28K9.70%3.23M8.73%876.4K
-General and administrative expense 154.53%1.5M128.68%1.5M108.44%1.58M-2.33%3.16M31.22%1.15M-21.19%590.62K-10.32%657.81K-13.12%757.28K9.70%3.23M8.73%876.4K
Research and development costs 163.11%2.59M52.96%1.73M70.10%1.64M132.24%13.01M858.35%9.92M-25.24%984.28K-29.08%1.13M-41.57%966.11K-26.23%5.6M-50.76%1.04M
Operating profit -159.89%-4.09M-80.81%-3.23M-86.95%-3.22M-83.01%-16.16M-479.22%-11.07M23.77%-1.57M23.17%-1.79M31.75%-1.72M16.19%-8.83M34.27%-1.91M
Net non-operating interest income expense 559.80%655.47K962.63%780.77K626.40%596.85K-5.83%404.02K51.96%149.04K-11.51%99.34K-42.70%73.48K-9.20%82.17K1,920.05%429.04K674.67%98.07K
Non-operating interest income 559.80%655.47K962.63%780.77K626.40%596.85K-5.83%404.02K51.96%149.04K-11.51%99.34K-42.70%73.48K-9.20%82.17K1,920.05%429.04K674.67%98.07K
Other net income (expense) 171.28K0171.28K
Other non- operating income (expenses) --------------171.28K--0--171.28K----------------
Income before tax -163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M
Income tax
Net income -163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M
Net income continuous Operations -163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M
Minority interest income
Net income attributable to the parent company -163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -163.56%-3.44M-43.04%-2.45M-59.94%-2.62M-85.50%-15.59M-502.32%-10.93M33.24%-1.3M22.03%-1.72M32.59%-1.64M20.10%-8.4M37.37%-1.81M
Basic earnings per share -29.73%-0.4828.57%-0.3525.49%-0.38-35.20%-4.11-350.82%-2.7546.38%-0.3738.75%-0.4946.32%-0.5126.75%-3.0446.96%-0.61
Diluted earnings per share -29.73%-0.4828.57%-0.3525.49%-0.38-35.20%-4.11-350.82%-2.7546.38%-0.3738.75%-0.4946.32%-0.5126.75%-3.0446.96%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More